Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura acquires two intranasal steroid products from Syntex

May 13, 1997

Sequana and Boehringer Ingelheim expand alliance for asthma research

May 12, 1997

Bradykinin antagonists from Fujisawa

May 9, 1997

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Sanofi claims HLE inhibitors

May 6, 1997

Nacystelyn promising alternative to NAC for lung antioxidant therapy

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Cortech and Ono amend research agreement

May 2, 1997

Japan Tobacco discloses cytokine inhibitors

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...